Sesame Health launches new $249 monthly program offering composite alternatives to Wegovy for weight loss
In a recent announcement, Sesame Health Marketplace introduced a new clinical weight-loss initiative aimed at providing consumers with affordable access to compounded versions of the widely acclaimed obesity treatment Wegovy, priced at $249 per month. This innovative platform facilitates direct interactions between patients and healthcare providers to schedule and pay for medical visits, bypassing traditional insurance processes. The move includes the addition of the compound semaglutide, the lead component of Wegovy and Novo Nordisk’s diabetes treatment Ozempic, to its platform. This addition is especially timely given the current market shortage of several leading branded drugs. Sesame’s portfolio already includes a…